Compound details
4-Hydroxyfurano[2\'\',3\'\':6,7]aurone
| Compound ID | CDAMM02856 |
|---|---|
| Common name | 4-Hydroxyfurano[2\'\',3\'\':6,7]aurone | IUPAC name | 2-benzylidene-3-hydroxyfuro[2,3-g][1]benzofuran-4-one |
| Molecular formula | C17H10O4 |
| Retention time | 7.38 |
|---|---|
| Adduct | [M+H]+ |
| Actual mz | 279.062 | Theoretical mz | 279.065 |
| Error | 11.02 |
| Ionizaton mode | Positive |
| Instrument type | LC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60 |
| Score | 6.8572 |
| Inchi key | NULUMMBDIFUOPU-UHFFFAOYSA-N |
|---|---|
| Smiles | O=C1C(OC2=C3C=COC3=CC(O)=C12)=CC=4C=CC=CC4 |
| Superclass | Phenylpropanoids and polyketides |
| Class | Aurone flavonoids |
| Uniprot ID | Gene name | Target name | TTD_ID | Prediction source |
|---|---|---|---|---|
| P21397 | MAOA | Monoamine oxidase A | T83875 | SEA |
| P27338 | MAOB | Monoamine oxidase B | T83011 | SEA |
| P22001 | KCNA3 | Voltage-gated potassium channel subunit Kv1.3 | T76914 | SEA |
| Q92952 | KCNN1 | Small conductance calcium-activated potassium channel protein 1 | T11911 | SEA |
| Q9H2S1 | KCNN2 | Small conductance calcium-activated potassium channel protein 2 | T86271 | SEA |
| Q92887 | CMOAT | Multidrug resistance-associated protein 2 | T61792 | SEA |
| Q96HK3 | CALM | Calmodulin | T39610 | SEA |
| Q09470 | KCNA1 | Voltage-gated potassium channel Kv1.1 | T85272 | SEA |
| Q96RP8 | KCNA7 | Voltage-gated potassium channel Kv1.7 | T84737 | SEA |
| P22459 | KCNA4 | Voltage-gated A-type potassium channel | T15665 | SEA |
| P16389 | KCNA2 | Voltage-gated potassium channel Kv1.2 | T19492 | SEA |
| TTD_ID | Disease_ID | Disease name | ICD_11 | Uniprot ID | Gene names |
|---|---|---|---|---|---|
| T83875 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P21397 | MAOA |
| T83875 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P21397 | MAOA |
| T83011 | DI0115 | Dementia | [ICD-11: 6D80-6D8Z] | P27338 | MAOB |
| T83011 | DI0117 | Depression | [ICD-11: 6A70-6A7Z] | P27338 | MAOB |
| T83011 | DI0190 | Hypertension | [ICD-11: BA00-BA04] | P27338 | MAOB |
| T83011 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | P27338 | MAOB |
| T83011 | DI0264 | Migraine | [ICD-11: 8A80] | P27338 | MAOB |
| T83011 | DI0331 | Parkinsonism | [ICD-11: 8A00] | P27338 | MAOB |
| T76914 | DI0198 | Idiopathic inflammatory myopathy | [ICD-11: 4A41] | P22001 | KCNA3 |
| T76914 | DI0351 | Psoriasis | [ICD-11: EA90] | P22001 | KCNA3 |
| T76914 | DI0352 | Psoriatic arthritis | [ICD-11: FA21] | P22001 | KCNA3 |
| T11911 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q92952 | KCNN1 |
| T86271 | DI0285 | Myelopathy | [ICD-11: 8B42] | Q9H2S1 | KCNN2 |
| T39610 | DI0068 | Cardiac arrhythmia | [ICD-11: BC9Z] | Q96HK3 | CALM |
| T39610 | DI0243 | Malaria | [ICD-11: 1F40-1F45] | Q96HK3 | CALM |
| T39610 | DI0370 | Schizophrenia | [ICD-11: 6A20] | Q96HK3 | CALM |